title: Commentary.
authors.affiliation: Department of Neurology, University of Toronto, Toronto, Ontario, Canada. sfox@uhnresearch.ca
authors.forename: Susan
authors.initials: S
authors.lastname: Fox
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000150:complications*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D020734:Parkinsonian Disorders / Q000188:drug therapy*; D013378:Substantia Nigra / Q000473:pathology*
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa